ENA man offered chemotherapy for prostate cancer usually hears it as a verdict: so things must be bad. Behind this lies an old view of chemotherapy as a last resort.
In fact, chemotherapy for prostate cancer in Germany is a standard option for advanced disease, often started with hormone treatment rather than after it fails. Below: its place in treatment today, why it is given early, how a course runs and what is done when it stops helping. General overview: prostate cancer treatment in Germany.
Where chemotherapy sits in prostate cancer treatment
Chemotherapy does not replace hormone treatment; it is added to it. Prostate cancer depends on male hormones, so the basis of treating advanced disease is suppressing them; see the page on hormone therapy in oncology.
The first situation is newly diagnosed advanced cancer with a large volume of spread: many bone metastases or metastases in internal organs. Chemotherapy is then added to hormone treatment straight away, today usually together with a newer hormonal drug, because this holds the disease back markedly longer than hormone suppression alone.
The second situation is disease that keeps growing despite hormone suppression, which reports call castration-resistant cancer. Here chemotherapy becomes one of the main options alongside newer hormonal drugs; see the page on advanced prostate cancer treatment. Hormone treatment and chemotherapy in advanced disease are also covered by a prostate cancer guide written with the German Cancer Research Center’s Cancer Information Service.
What is established before starting
The tumour board first checks whether chemotherapy is needed and can be tolerated. It looks at the PSA and how fast it rises, where the metastases are and how many, the pathology report with the tumour grade, and recent imaging, in German centres most often a PSMA PET-CT, which finds prostate cancer deposits. General condition, heart, kidneys and blood counts are assessed separately, because tolerance depends on them.
Tests now done before choosing treatment look for mutations in DNA repair genes, including BRCA, and for signs of microsatellite instability, a fault in another DNA repair system. Such findings can move the conversation from chemotherapy to a different drug, which is exactly why patients are asked to bring the slides and blocks. More on advanced disease: stage 4 prostate cancer treatment.
How a course runs
Chemotherapy for prostate cancer in Germany is given in cycles: a short infusion in a day clinic, then a break to recover. The backbone is a taxane, usually docetaxel; the number of cycles is decided by the treating doctor.
A port, a small chamber under the skin connected to a large vein, often spares searching for a vein each time. Blood is tested before every infusion, and PSA and imaging are checked during the course. Hormone treatment continues throughout: chemotherapy does not replace it, although many people think it does. Bone complications are prevented too.
This is done in uro-oncology centres and oncology departments. At University Hospital Essen, for example, the uro-oncology centre is headed by Prof. Boris Hadaschik, and at the Red Cross Clinic Munich the department of haematology and oncology, the cancer centre and the field of urogenital tumours are led by Prof. Marcus Hentrich.
Side effects and how they are managed
Taxane side effects are known in advance and managed by routine. The most common are tiredness, falling blood counts with a risk of infection, nausea, hair loss, numbness in the hands and feet, swelling and a changed sense of taste. German departments prescribe supportive treatment before the first infusion.
Anti-sickness drugs follow a set regimen, blood counts are checked on schedule and supportive drugs are given if white cells fall too low; for numbness, the doctor changes the dose or rhythm of infusions. The key rule: a temperature above 38.3 °C, or of 38 °C or more for at least an hour, means calling the department at once, the same day.
Much also depends on the patient: a dentist visit before the course, especially if bone drugs are planned, exercise within what is tolerated, drinking enough and a symptom diary. Bone protection and checks of vitamin D and calcium are part of the plan, not an optional supplement.
What is done if chemotherapy stops working
A rising PSA during treatment is a signal to review the plan, not the end of treatment. The tumour board chooses among options: a second taxane, cabazitaxel; newer hormonal drugs; targeted treatment such as PARP inhibitors if mutations are found; radioligand therapy with lutetium for PSMA-positive tumours; radiotherapy to painful spots.
Alongside this come pain relief, bone protection, physiotherapy and the palliative care service, which in Germany works with the oncologists rather than after them. How long-term treatment is costed is explained on the page on the cost of prostate cancer treatment.
Frequently asked questions
Is hormone treatment stopped during chemotherapy?
No, it continues during chemotherapy and afterwards. Chemotherapy works differently and does not replace hormone suppression, so injections or tablets from the urologist are not stopped without a doctor’s decision. Treatment started at home is not paused for the trip; the doctors in Germany decide what to add.
How long does a course of chemotherapy for prostate cancer last?
It depends on the number of cycles, which the doctor sets by how the disease responds and how treatment is tolerated. Each infusion is followed by a recovery break, so the course takes time; where each cycle is given is agreed in advance. Hormone treatment continues afterwards.
Can some cycles of chemotherapy be given at home?
Yes, if the doctor in Germany considers it safe and a department at home can follow the same plan. Who looks after the patient between cycles, how results reach the German doctor and when a check-up in Germany is due are agreed in advance; the written plan is translated for the home doctor.
How AlenMed arranges the treatment
AlenMed starts with the documents: histology with slides and blocks, the PSA trend, PET-CT and CT, discharge letters listing previous treatment and laboratory results go to the department, whose doctor says whether chemotherapy is indicated, how many cycles are under discussion and which can be given at home. Then come a written estimate, a visa invitation, back-to-back appointments and an interpreter.
The treatment is long, so who supervises between cycles and how results are passed on is agreed in advance. Plan also for a companion, accommodation near the hospital and a translation of the treatment plan for the doctor at home.
This material is for information only and is not an offer. The treatment plan is decided by a doctor at an in-person consultation.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
